Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Yervoy

Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   



magnesium1 - kidney care1 - routine antenatal sonography1 - ungal1 - methylation1 - prostate-specific antigen test1 - zytiga5 - peritoneum1 - ufe1 - single kidney1 - screening test1 - hypokalemia1 - urine is sterile1 - acupuncture1 - prostate specific antigen6 - bph3 - hypoxia1 - cystectomy1 - treatment of prostate cancer1 - magnetic resonance prostate imaging reporting1 - bony pelvis3 - urinary tract problems1 - rsna1 - pelvic ureter1 - pelvic viscera1 - kidney cancer subtypes1 - premature death3 - stenoses1 - leak-point pressure4 - cancerous tissue1 -